DE1356047U - - Google Patents

Info

Publication number
DE1356047U
DE1356047U DENDAT1356047D DE1356047DU DE1356047U DE 1356047 U DE1356047 U DE 1356047U DE NDAT1356047 D DENDAT1356047 D DE NDAT1356047D DE 1356047D U DE1356047D U DE 1356047DU DE 1356047 U DE1356047 U DE 1356047U
Authority
DE
Germany
Prior art keywords
ttur36id
hantstz
alis
rch
protection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1356047D
Other languages
German (de)
English (en)
Publication of DE1356047U publication Critical patent/DE1356047U/de
Active legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
DENDAT1356047D Active DE1356047U (enrdf_load_stackoverflow)

Publications (1)

Publication Number Publication Date
DE1356047U true DE1356047U (enrdf_load_stackoverflow)

Family

ID=670392

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1356047D Active DE1356047U (enrdf_load_stackoverflow)

Country Status (1)

Country Link
DE (1) DE1356047U (enrdf_load_stackoverflow)

Similar Documents

Publication Publication Date Title
Tavares et al. 3′-Azido-3′-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS
Mervis et al. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors
Kornbluth et al. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro.
Chesebro et al. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity
Rayfield et al. Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction
Lazdins et al. In vitro effect of transforming growth factor-beta on progression of HIV-1 infection in primary mononuclear phagocytes
Hayashi et al. Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro
Rook et al. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
CA1332687C (en) Disinfectant and/or sanitizing cleaner compositions
Pluda et al. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy
YAMAMOTO et al. Experimental vaccine protection against feline immunodeficiency virus
Lucht et al. Periodontal disease in HIV‐infected patients in relation to lymphocyte subsets and specific micro‐organisms
SI9200297B (sl) Antagonisti endotelinskih receptorjev
DE1356047U (enrdf_load_stackoverflow)
US4900548A (en) Use of diethylcarbamazine to enhance antigen-antibody and antigen-host immune cell interactions
Craig et al. Antiviral synergy between inhibitors of HIV proteinase and reverse transcriptase
Cloyd et al. How does HIV cause depletion of CD4 lymphocytes? A mechanism involving virus signaling through its cellular receptors
Richman Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1
Denis et al. Alveolar macrophages from subjects infected with HIV‐1 express macrophage inflammatory protein‐1α (MIP‐1α): contribution to the CD8+ alveolitis
Armand-Ugón et al. Reduced fitness of HIV-1 resistant to CXCR4 antagonists
US20060073221A1 (en) Compositions for the treatment of acquired immunodeficiency disease
Shapshak et al. HIV-1 propagates in human neuroblastoma cells
Brigham A strain of endemic typhus fever isolated from a field mouse
Abb et al. HIV antigen, HIV antibody and serum interferon in a patient with encephalopathy
US5164376A (en) Method for treating retroviral infections with aryl-(2-pyrryl) keytone compound